Work

1229P Precision patient selection for postoperative therapy in resectable NSCLC: A comprehensive postoperative-risk model incorporating genetic and histological features

Year: 2024

Type: article

Study design: Observational Study

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2024.08.1288

Authors: Y. Ye, S. Zhang, J. Qian, G. Cai, W. Xia, W. Wang

Institutions: First Affiliated Hospital of Anhui Medical University, Anhui Medical University, University of Science and Technology of China

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Mesothelioma Applied Research Foundation, Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, Sanofi, Leukemia and Lymphoma Society, Gilead Sciences, International Association for the Study of Lung Cancer, American Society of Clinical Oncology, Celgene, University of Miami, F. Hoffmann-La Roche, Jazz Pharmaceuticals, Society for Immunotherapy of Cancer, Novocure, Les Laboratories Pierre Fabre, Agios Pharmaceuticals, Jounce Therapeutics, BeiGene, Incyte, Apellis Pharmaceuticals, National Natural Science Foundation of China, Astellas Pharma, Servier, Ipsen, Aptitude Health, LEO Pharma, National Institutes of Health, Genentech, EMD Serono, Chugai Pharmaceutical, Takeda Oncology, Sanofi Genzyme, Natural Science Foundation of Anhui Province, National Cancer Institute, National Institute of Nursing Research, Daiichi Sankyo Europe

Awards: G2116340504, RBPJ功能缺失对皮肤鳞癌肿瘤干细胞特性的影响及其机制研究, G6038431638, G6764879178

OpenAlex ID: W4402560662

FWCI:

Cites:

Cited by:

Related to: 10